» Articles » PMID: 17419583

Ultrasound-mediated Gene Delivery: Influence of Contrast Agent on Transfection

Overview
Journal Bioconjug Chem
Specialty Biochemistry
Date 2007 Apr 11
PMID 17419583
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

MAT B III cells were insonified at ultrasound frequencies of 1.15 and 2.25 MHz in the presence of different ultrasound contrast agents (UCA) and a plasmid encoding for the green fluorescent protein. The transfection efficiency was assessed by flow cytometry, while contrast agent destruction by ultrasound was evaluated using optical and scanning electronic microscopies. It was found that the gas and shell properties of the UCA have an important influence on cell transfection. A good correlation was observed between bubble destruction and transfection rate, and it was demonstrated, for the first time, that hard-shelled contrast agents (gas microcapsules) are promising candidates for ultrasound-mediated gene delivery.

Citing Articles

Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.

Zhang N, Wang J, Foiret J, Dai Z, Ferrara K Adv Drug Deliv Rev. 2021; 178:113906.

PMID: 34333075 PMC: 8556319. DOI: 10.1016/j.addr.2021.113906.


The relation of Bleomycin Delivery Efficiency to Microbubble Sonodestruction and Cavitation Spectral Characteristics.

Maciulevicius M, Tamosiunas M, Venslauskas M, Satkauskas S Sci Rep. 2020; 10(1):7743.

PMID: 32385397 PMC: 7210292. DOI: 10.1038/s41598-020-64213-y.


Mechanistic Insight into Sonoporation with Ultrasound-Stimulated Polymer Microbubbles.

Helfield B, Chen X, Qin B, Watkins S, Villanueva F Ultrasound Med Biol. 2017; 43(11):2678-2689.

PMID: 28847500 PMC: 5644032. DOI: 10.1016/j.ultrasmedbio.2017.07.017.


Influence of DNA-Microbubble Coupling on Contrast Ultrasound-Mediated Gene Transfection in Muscle and Liver.

Xie A, Wu M, Cigarroa G, Belcik J, Ammi A, Moccetti F J Am Soc Echocardiogr. 2016; 29(8):812-818.

PMID: 27267307 PMC: 6454880. DOI: 10.1016/j.echo.2016.04.011.


Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.

Fan C, Ting C, Lin C, Chan H, Chang Y, Chen Y Sci Rep. 2016; 6:19579.

PMID: 26786201 PMC: 4726227. DOI: 10.1038/srep19579.